Status:

TERMINATED

Techniques to Reduce the Severity and Frequency of Emergent Reactions

Lead Sponsor:

CHRISTUS Health

Conditions:

Analgesia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objectives of this study are first to determine if the power of suggestion will decrease the frequency and severity of emergence reactions after procedural sedation and analgesia with ketamine in ...

Detailed Description

The proposed research will be single blinded (patient) randomized controlled trial with a retrospective component to test the hypothesis that the power of suggestion will reduce the frequency and seve...

Eligibility Criteria

Inclusion

  • Be at least 18 years of age
  • Required need for procedural sedation and analgesia

Exclusion

  • Age\< 18
  • Hypertension
  • Raised Intracranial pressure
  • Major psychological disorders
  • Procedures involving laryngel manipulations
  • History of Laryngeal sapsm History of adverse reactions to ketamine

Key Trial Info

Start Date :

November 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 21 2021

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT03832309

Start Date

November 21 2017

End Date

June 21 2021

Last Update

April 6 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHRISTUS Health

Corpus Christi, Texas, United States, 78404